| Title |
Neurobiology of autism gene products: towards pathogenesis and drug targets
|
|---|---|
| Published in |
Psychopharmacology, January 2014
|
| DOI | 10.1007/s00213-013-3403-3 |
| Pubmed ID | |
| Authors |
Kristel T. E. Kleijer, Michael J. Schmeisser, Dilja D. Krueger, Tobias M. Boeckers, Peter Scheiffele, Thomas Bourgeron, Nils Brose, J. Peter H. Burbach |
| Abstract |
The genetic heterogeneity of autism spectrum disorders (ASDs) is enormous, and the neurobiology of proteins encoded by genes associated with ASD is very diverse. Revealing the mechanisms on which different neurobiological pathways in ASD pathogenesis converge may lead to the identification of drug targets. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 3 | 2% |
| Iceland | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 173 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 32 | 18% |
| Researcher | 30 | 17% |
| Student > Ph. D. Student | 29 | 16% |
| Student > Bachelor | 22 | 12% |
| Student > Postgraduate | 11 | 6% |
| Other | 25 | 14% |
| Unknown | 29 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 39 | 22% |
| Medicine and Dentistry | 28 | 16% |
| Neuroscience | 27 | 15% |
| Psychology | 16 | 9% |
| Biochemistry, Genetics and Molecular Biology | 13 | 7% |
| Other | 20 | 11% |
| Unknown | 35 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2014.
All research outputs
#20,880,816
of 25,654,806 outputs
Outputs from Psychopharmacology
#4,649
of 5,352 outputs
Outputs of similar age
#245,574
of 322,602 outputs
Outputs of similar age from Psychopharmacology
#54
of 68 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,352 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,602 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.